Discontinuation report GLUCAGEN
Report ID | 198040 |
Drug Identification Number | 02333619 |
Brand name | GLUCAGEN |
Common or Proper name | Glucagen |
Company Name | NOVO NORDISK CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | GLUCAGON |
Strength(s) | 1MG |
Dosage form(s) | POWDER FOR SOLUTION KIT |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 1 |
ATC code | H04AA |
ATC description | GLYCOGENOLYTIC HORMONES |
Reason for discontinuation | Manufacturing issues |
Anticipated discontinuation date | 2024-02-29 |
Actual discontinuation date | 2024-02-29 |
Remaining supply date | 2024-02-29 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 101-2476 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 6M1 |
Company contact information | 1 800 465 4334 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2024-03-06 | French | Compare |
v12 | 2024-03-06 | English | Compare |
v11 | 2024-02-06 | French | Compare |
v10 | 2024-02-06 | English | Compare |
v9 | 2023-07-10 | French | Compare |
v8 | 2023-07-10 | English | Compare |
v7 | 2023-07-10 | French | Compare |
v6 | 2023-07-10 | English | Compare |
v5 | 2023-07-10 | French | Compare |
v4 | 2023-07-10 | French | Compare |
v3 | 2023-07-10 | French | Compare |
v2 | 2023-07-10 | English | Compare |
v1 | 2023-07-10 | English | Compare |
Showing 1 to 13 of 13